Chemoradiotherapy for Oesophageal Cancer with Malignant Stricture
Author Information
Author(s): Kaneko K, Ito H, Konishi K, Kurahashi T, Ito T, Katagiri A, Yamamoto T, Kitahara T, Mizutani Y, Ohtsu A, Mitamura K
Primary Institution: Showa University School of Medicine
Hypothesis
The study investigates the efficacy and feasibility of chemoradiotherapy for patients with malignant stricture caused by squamous cell carcinoma of the oesophagus.
Conclusion
Chemoradiotherapy can improve dysphagia and survival rates in patients with advanced oesophageal cancer.
Supporting Evidence
- Chemoradiotherapy improved dysphagia in 81% of patients.
- 24 patients achieved complete response (CR) with chemoradiotherapy.
- The median survival time for T3 patients was 29 months, while for T4 it was 11 months.
- Significant toxicity was observed, including leukocytopenia and oesophagitis.
- Patients with T4 disease had a lower CR rate compared to T3 disease.
Takeaway
This study shows that a special treatment can help people with a serious swallowing problem caused by cancer in the food pipe.
Methodology
The study evaluated 57 patients with advanced oesophageal cancer, analyzing the effects of chemoradiotherapy on dysphagia and survival.
Potential Biases
Potential bias in patient selection and treatment evaluation.
Limitations
The study is retrospective and may have selection bias due to the exclusion of patients with certain conditions.
Participant Demographics
57 patients, 47 men and 10 women, median age 64 years.
Statistical Information
P-Value
0.009
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website